Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 5,864

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

Open access
Developed with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors/Task Force Members, Camm, A. J., Kirchhof, P., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Van Gelder, I. C., Al-Attar, N., Hindricks, G., Prendergast, B., Heidbuchel, H., Alfieri, O., Angelini, A., Atar, D., Colonna, P., De Caterina, R., De Sutter, J., Goette, A., Gorenek, B., Heldal, M., Hohloser, S. H., Kolh, P., Le Heuzey, J.-Y., Ponikowski, P., Rutten, F. H., ESC Committee for Practice Guidelines (CPG), Vahanian, A., Auricchio, A., Bax, J., Ceconi, C., Dean, V., Filippatos, G., Funck-Brentano, C., Hobbs, R., Kearney, P., McDonagh, T., Popescu, B. A., Reiner, Z., Sechtem, U., Sirnes, P. A., Tendera, M., Vardas, P. E., Widimsky, P., Document Reviewers, Vardas, P. E., Agladze, V., Aliot, E., Balabanski, T., Blomstrom-Lundqvist, C., Capucci, A., Crijns, H., Dahlof, B., Folliguet, T., Glikson, M., Goethals, M., Gulba, D. C., Ho, S. Y., Klautz, R. J. M., Kose, S., McMurray, J., Perrone Filardi, P., Raatikainen, P., Salvador, M. J., Schalij, M. J., Shpektor, A., Sousa, J., Stepinska, J., Uuetoa, H., Zamorano, J. L., Zupan, I.·2010·European Heart Journal
DOI 10.1093/eurheartj/ehq278
Open this paper in CoChat — free account

Abstract

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, occurring in 1–2% of the general population. Over 6 million Europeans suffer from this arrhythmia, and its prevalence is estimated to at least double in the next 50 years as the population ages. It is now 4 years since the last AF guideline was published, and a new version is now needed. AF confers a 5-fold risk of stroke, and one in five of all strokes is attributed to this arrhythmia. Ischaemic strokes in association with AF are often fatal, and those patients who survive are left more disabled by their stroke and more likely to suffer a recurrence than patients with other causes of stroke. In consequence, the risk of death from AF-related stroke is doubled and the cost of care is increased 1.5-fold. There has been much research into stroke prevention, which has influenced this guideline. In the majority of patients there appears to be an inexorable progression of AF to persistent or permanent forms, associated with further development of the disease that may underlie the arrhythmia. Some advance has been made in the understanding of the dynamic development of AF from its preclinical state as an ‘arrhythmia-in-waiting’ to its final expression as an irreversible and end-stage cardiac arrhythmia associated with serious adverse cardiovascular events. Much recent therapeutic effort with ‘upstream therapies’ has been expended to slow or halt the progression of AF due to underlying cardiovascular disease and to AF itself. Limited success has been achieved and is recognized in this guideline.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehq278

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Research works printed but not linked: 153

  1. Kirchhof, 2007, Outcome parameters for trials in atrial fibrillation: executive summary. Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA), Eur Heart J, 28, 2803, 10.1093/eurheartj/ehm358 · DOI · Paper page
  2. Lip, 1997, A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project, Br J Gen Pract, 47, 285
  3. Naccarelli, 2009, Increasing prevalence of atrial fibrillation and flutter in the United States, Am J Cardiol, 104, 1534, 10.1016/j.amjcard.2009.07.022 · DOI · Paper page
  4. Hylek, 2003, Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation, N Engl J Med, 349, 1019, 10.1056/NEJMoa022913 · DOI · Paper page
  5. Knecht, 2008, Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy, Eur Heart J, 29, 2125, 10.1093/eurheartj/ehn341 · DOI · Paper page
  6. Friberg, 2010, Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation, Eur Heart J, 31, 967, 10.1093/eurheartj/ehn599 · DOI · Paper page
  7. Nieuwlaat, 2005, Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation, Eur Heart J, 26, 2422, 10.1093/eurheartj/ehi505 · DOI · Paper page
  8. Nabauer, 2009, The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management, Europace, 11, 423, 10.1093/europace/eun369 · DOI · Paper page
  9. Maron, 2006, Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention, Circulation, 113, 1807, 10.1161/CIRCULATIONAHA.106.174287 · DOI · Paper page
  10. Goette, 2009, Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles, Eur Heart J, 30, 1411, 10.1093/eurheartj/ehp046 · DOI
  11. Schotten, 2010, Pathophysiological mechanisms of atrial fibrillation—a translational appraisal, Physiol Rev
  12. Daoud, 1996, Effect of atrial fibrillation on atrial refractoriness in humans, Circulation, 94, 1600, 10.1161/01.CIR.94.7.1600 · DOI · Paper page
  13. Frustaci, 1997, Histological substrate of atrial biopsies in patients with lone atrial fibrillation, Circulation, 96, 1180, 10.1161/01.CIR.96.4.1180 · DOI · Paper page
  14. Haissaguerre, 1998, Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins, N Engl J Med, 339, 659, 10.1056/NEJM199809033391003 · DOI · Paper page
  15. Hodgson-Zingman, 2008, Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation, N Engl J Med, 359, 158, 10.1056/NEJMoa0706300 · DOI · Paper page
  16. Olson, 2005, Sodium channel mutations and susceptibility to heart failure and atrial fibrillation, JAMA, 293, 447, 10.1001/jama.293.4.447 · DOI · Paper page
  17. Chen, 2003, KCNQ1 gain-of-function mutation in familial atrial fibrillation, Science, 299, 251, 10.1126/science.1077771 · DOI · Paper page
  18. Packer, 1986, Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction, Am J Cardiol, 57, 563, 10.1016/0002-9149(86)90836-2 · DOI · Paper page
  19. Watson, 2009, Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited, Lancet, 373, 155, 10.1016/S0140-6736(09)60040-4 · DOI · Paper page
  20. Blomstrom-Lundqvist, 2003, ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias—executive summary. a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society, J Am Coll Cardiol, 42, 1493
  21. Jahangir, 2007, Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study, Circulation, 115, 3050, 10.1161/CIRCULATIONAHA.106.644484 · DOI · Paper page
  22. Calkins, 2007, HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society, Europace, 9, 335, 10.1093/europace/eum120 · DOI · Paper page
  23. Jabaudon, 2004, Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack, Stroke, 35, 1647, 10.1161/01.STR.0000131269.69502.d9 · DOI · Paper page
  24. Israel, 2004, Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care, J Am Coll Cardiol, 43, 47, 10.1016/j.jacc.2003.08.027 · DOI · Paper page
  25. Ziegler, 2006, Comparison of continuous versus intermittent monitoring of atrial arrhythmias, Heart Rhythm, 3, 1445, 10.1016/j.hrthm.2006.07.030 · DOI · Paper page
  26. Hindricks, 2010, Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation—results of the XPECT trial, Circ Arrhythm Electrophysiol, 3, 141, 10.1161/CIRCEP.109.877852 · DOI · Paper page
  27. Dorian, 2009, Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale, Circ Arrhythm Electrophysiol, 2, 218, 10.1161/CIRCEP.108.812347 · DOI · Paper page
  28. Klein, 2001, Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation, N Engl J Med, 344, 1411, 10.1056/NEJM200105103441901 · DOI · Paper page
  29. Fitzmaurice, 2007, Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial, BMJ, 335
  30. Dickstein, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM), Eur Heart J 2008, 29, 2388
  31. Haverkamp, 2000, The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology, Eur Heart J, 21, 1216, 10.1053/euhj.2000.2249 · DOI · Paper page
  32. Stroke in AF working group, 2007, Independent predictors of stroke in patients with atrial fibrillation: a systematic review, Neurology, 69, 546, 10.1212/01.wnl.0000267275.68538.8d · DOI · Paper page
  33. Schmitt, 2009, Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications, Eur Heart J, 30, 1038, 10.1093/eurheartj/ehn579 · DOI · Paper page
  34. Gage, 2001, Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation, JAMA, 285, 2864, 10.1001/jama.285.22.2864 · DOI · Paper page
  35. Go, 2003, Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?, JAMA, 290, 2685, 10.1001/jama.290.20.2685 · DOI · Paper page
  36. Lip, 2010, Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation, Chest, 137, 263, 10.1378/chest.09-1584 · DOI · Paper page
  37. Lip, 2010, Identifying patients at risk of stroke despite anticoagulation, Stroke
  38. Sato, 2006, Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial, Stroke, 37, 447, 10.1161/01.STR.0000198839.61112.ee · DOI · Paper page
  39. Pisters, 2010, A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey, Chest, 10.1378/chest.10-0134 · DOI · Paper page
  40. Lip, 2010, Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting, Thromb Haemost, 103, 13, 10.1160/TH09-08-0580 · DOI · Paper page
  41. Holmes, 2009, Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial, Lancet, 374, 534, 10.1016/S0140-6736(09)61343-X · DOI · Paper page
  42. Singer, 2008, Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition), Chest, 133
  43. Vahanian, 2007, Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology, Eur Heart J, 28, 230, 10.1093/eurheartj/ehl428 · DOI · Paper page
  44. Fang, 2006, Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study, J Am Geriatr Soc, 54, 1231, 10.1111/j.1532-5415.2006.00828.x · DOI · Paper page
  45. Poldermans, 2010, Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA), Eur J Anaesthesiol, 27, 92, 10.1097/EJA.0b013e328334c017 · DOI · Paper page
  46. Kowey, 2009, Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial, Circ Arrhythm Electrophysiol, 2, 652, 10.1161/CIRCEP.109.870204 · DOI · Paper page
  47. Roy, 2008, Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial, Circulation, 117, 1518, 10.1161/CIRCULATIONAHA.107.723866 · DOI · Paper page
  48. Camm, 2010, A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent onset atrial fibrillation, J Am Coll Cardiol
  49. Reisinger, 2004, Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset, Eur Heart J, 25, 1318, 10.1016/j.ehj.2004.04.030 · DOI
  50. Khan, 2001, Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation, J Am Coll Cardiol, 37, 542, 10.1016/S0735-1097(00)01116-5 · DOI
  51. Martinez-Marcos, 2000, Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm, Am J Cardiol, 86, 950, 10.1016/S0002-9149(00)01128-0 · DOI · Paper page
  52. Vardas, 2000, Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study, Chest, 117, 1538, 10.1378/chest.117.6.1538 · DOI
  53. Kirchhof, 2002, Anterior–posterior versus anterior–lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial, Lancet, 360, 1275, 10.1016/S0140-6736(02)11315-8 · DOI · Paper page
  54. Oral, 1999, Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment, N Engl J Med, 340, 1849, 10.1056/NEJM199906173402401 · DOI · Paper page
  55. Manios, 2003, Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence rates: a randomized controlled study, Cardiovasc Drugs Ther, 17, 31, 10.1023/A:1024203824761 · DOI
  56. Bianconi, 1996, Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study, J Am Coll Cardiol, 28, 700, 10.1016/S0735-1097(96)00230-6 · DOI
  57. Gulamhusein, 1982, Acceleration of the ventricular response during atrial fibrillation in the Wolff–Parkinson–White syndrome after verapamil, Circulation, 65, 348, 10.1161/01.CIR.65.2.348 · DOI · Paper page
  58. Cosio, 2008, Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode, Europace, 10, 21, 10.1093/europace/eum276 · DOI
  59. Kirchhof, 2009, Can we improve outcomes in atrial fibrillation patients by early therapy?, BMC Med, 7
  60. Van Gelder, 2002, A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation, N Engl J Med, 347, 1834, 10.1056/NEJMoa021375 · DOI · Paper page
  61. Carlsson, 2003, Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation, J Am Coll Cardiol, 41, 1690, 10.1016/S0735-1097(03)00332-2 · DOI · Paper page
  62. Opolski, 2004, Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study, Chest, 126, 476, 10.1378/chest.126.2.476 · DOI · Paper page
  63. Ogawa, 2009, Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study, Circ J, 73, 242, 10.1253/circj.CJ-08-0608 · DOI · Paper page
  64. Hohnloser, 2000, Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial, Lancet, 356, 1789, 10.1016/S0140-6736(00)03230-X · DOI · Paper page
  65. Hsu, 2004, Catheter ablation for atrial fibrillation in congestive heart failure, N Engl J Med, 351, 2373, 10.1056/NEJMoa041018 · DOI · Paper page
  66. Khan, 2008, Pulmonary-vein isolation for atrial fibrillation in patients with heart failure, N Engl J Med, 359, 1778, 10.1056/NEJMoa0708234 · DOI · Paper page
  67. Hohnloser, 2009, Effect of dronedarone on cardiovascular events in atrial fibrillation, N Engl J Med, 360, 668, 10.1056/NEJMoa0803778 · DOI · Paper page
  68. Wilber, 2010, Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial, JAMA, 303, 333, 10.1001/jama.2009.2029 · DOI · Paper page
  69. Talajic, 2010, Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation, J Am Coll Cardiol, 55, 1796, 10.1016/j.jacc.2010.01.023 · DOI
  70. Singh, 2007, Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter, N Engl J Med, 357, 987, 10.1056/NEJMoa054686 · DOI · Paper page
  71. Segal, 2000, The evidence regarding the drugs used for ventricular rate control, J Fam Pract, 49, 47
  72. Hou, 1995, Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study, Eur Heart J, 16, 521, 10.1093/oxfordjournals.eurheartj.a060945 · DOI · Paper page
  73. Redfearn, 2005, Use of medications in Wolff–Parkinson–White syndrome, Expert Opin Pharmacother, 6, 955, 10.1517/14656566.6.6.955 · DOI
  74. Davy, 2008, Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study, Am Heart J, 156
  75. Murgatroyd, 1999, Double-blind placebo-controlled trial of digoxin in symptomatic paroxysmal atrial fibrillation, Circulation, 99, 2765, 10.1161/01.CIR.99.21.2765 · DOI
  76. Gasparini, 2008, Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation, Eur Heart J, 29, 1644, 10.1093/eurheartj/ehn133 · DOI · Paper page
  77. Ozcan, 2001, Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation, N Engl J Med, 344, 1043, 10.1056/NEJM200104053441403 · DOI · Paper page
  78. Weerasooriya, 2003, The Australian intervention randomized control of rate in atrial fibrillation trial (AIRCRAFT), J Am Coll Cardiol, 41, 1697, 10.1016/S0735-1097(03)00338-3 · DOI · Paper page
  79. Upadhyay, 2008, Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies, J Am Coll Cardiol, 52, 1239, 10.1016/j.jacc.2008.06.043 · DOI · Paper page
  80. Auricchio, 2007, Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy, Am J Cardiol, 99, 232, 10.1016/j.amjcard.2006.07.087 · DOI
  81. Dong, 2010, Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy, Heart Rhythm, 10.1016/j.hrthm.2010.02.011 · DOI
  82. Lafuente-Lafuente, 2007, Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation, Cochrane Database Syst Rev, 4, 10.1002/14651858.CD005049.pub2 · DOI
  83. McNamara, 2001, Management of new onset atrial fibrillation (evidence report/Technology assessment), Agency for Heathcare Research and Quality
  84. Connolly, 1999, Evidence-based analysis of amiodarone efficacy and safety, Circulation, 100, 2025, 10.1161/01.CIR.100.19.2025 · DOI · Paper page
  85. Kääb, 2003, Sotalol testing unmasks altered repolarization in patients with suspected acquired long-QT-syndrome-a case-control pilot study using i.v. sotalol, Eur Heart J, 24, 649, 10.1016/S0195-668X(02)00806-0 · DOI · Paper page
  86. Le Heuzey, 2010, A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study, J Cardiovasc Electrophysiol, 21, 597, 10.1111/j.1540-8167.2010.01764.x · DOI · Paper page
  87. Kober, 2008, Increased mortality after dronedarone therapy for severe heart failure, N Engl J Med, 358, 2678, 10.1056/NEJMoa0800456 · DOI · Paper page
  88. Karlson, 1988, Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study, Eur Heart J, 9, 284, 10.1093/oxfordjournals.eurheartj.a062498 · DOI
  89. Crijns, 1996, Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group, Cardiovasc Drugs Ther, 10, 145, 10.1007/BF00823592 · DOI
  90. Piccini, 2009, Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation, J Am Coll Cardiol, 54, 1089, 10.1016/j.jacc.2009.04.085 · DOI · Paper page
  91. Singh, 2010, Dronedarone for atrial fibrillation: have we expanded the antiarrhythmic armamentarium, J Am Coll Cardiol, 55, 1569, 10.1016/j.jacc.2009.10.071 · DOI
  92. Freemantle, 2009, Morbidity and mortality associated with anti-arrhythmic drugs in atrial fibrillation: a systematic review and mixed treatment meta-analysis (abstract), Circulation, 120, S691
  93. Echt, 1991, Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial, N Engl J Med, 324, 781, 10.1056/NEJM199103213241201 · DOI · Paper page
  94. Roy, 2000, Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators, N Engl J Med, 342, 913, 10.1056/NEJM200003303421302 · DOI · Paper page
  95. Singh, 1995, Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure, N Engl J Med, 333, 77, 10.1056/NEJM199507133330201 · DOI · Paper page
  96. Van Gelder, 1989, Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter, Am J Cardiol, 64, 1317, 10.1016/0002-9149(89)90574-2 · DOI · Paper page
  97. Shah, 2008, Long-term outcome following successful pulmonary vein isolation: pattern and prediction of very late recurrence, J Cardiovasc Electrophysiol, 19, 661, 10.1111/j.1540-8167.2008.01101.x · DOI · Paper page
  98. Cappato, 2009, Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation, J Am Coll Cardiol, 53, 1798, 10.1016/j.jacc.2009.02.022 · DOI · Paper page
  99. Noheria, 2008, Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review, Arch Intern Med, 168, 581, 10.1001/archinte.168.6.581 · DOI · Paper page
  100. Jais, 2008, Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study, Circulation, 118, 2498, 10.1161/CIRCULATIONAHA.108.772582 · DOI · Paper page
  101. Pappone, 2006, A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study, J Am Coll Cardiol, 48, 2340, 10.1016/j.jacc.2006.08.037 · DOI · Paper page
  102. Blanc, 2008, Consensus document on antithrombotic therapy in the setting of electrophysiological procedures, Europace, 10, 513, 10.1093/europace/eun104 · DOI
  103. Piccini, 2009, Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials, Circ Arrhythm Electrophysiol, 2, 626, 10.1161/CIRCEP.109.856633 · DOI · Paper page
  104. Nair, 2009, A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation, J Cardiovasc Electrophysiol, 20, 138, 10.1111/j.1540-8167.2008.01285.x · DOI
  105. Ngaage, 2007, Influence of preoperative atrial fibrillation on late results of mitral repair: is concomitant ablation justified?, Ann Thorac Surg, 84, 434, 10.1016/j.athoracsur.2007.04.036 · DOI · Paper page
  106. Gaita, 2005, Linear cryoablation of the left atrium versus pulmonary vein cryoisolation in patients with permanent atrial fibrillation and valvular heart disease: correlation of electroanatomic mapping and long-term clinical results, Circulation, 111, 136, 10.1161/01.CIR.0000151310.00337.FA · DOI · Paper page
  107. Cox, 1991, Successful surgical treatment of atrial fibrillation. Review and clinical update, JAMA, 266, 1976, 10.1001/jama.1991.03470140088029 · DOI · Paper page
  108. Gaita, 2002, Surgical approaches to atrial fibrillation, Card Electrophysiol Rev, 6, 401, 10.1023/A:1021184324825 · doi:10.1023/a:1021184324825
  109. Savelieva, 2007, Is there any hope for angiotensin-converting enzyme inhibitors in atrial fibrillation?, Am Heart J, 154, 403, 10.1016/j.ahj.2007.05.008 · DOI
  110. Healey, 2005, Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis, J Am Coll Cardiol, 45, 1832, 10.1016/j.jacc.2004.11.070 · DOI · Paper page
  111. Anand, 2006, Meta-analysis: inhibition of renin–angiotensin system prevents new-onset atrial fibrillation, Am Heart J, 152, 217, 10.1016/j.ahj.2006.01.007 · DOI · Paper page
  112. Schmieder, 2008, Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial, J Hypertens, 26, 403, 10.1097/HJH.0b013e3282f35c67 · DOI · Paper page
  113. Madrid, 2002, Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study, Circulation, 106, 331, 10.1161/01.CIR.0000022665.18619.83 · DOI · Paper page
  114. Tveit, 2007, Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation, Am J Cardiol, 99, 1544, 10.1016/j.amjcard.2007.01.030 · DOI
  115. Yin, 2006, Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation, Eur Heart J, 27, 1841, 10.1093/eurheartj/ehl135 · DOI
  116. Belluzzi, 2009, Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients, J Am Coll Cardiol, 53, 24, 10.1016/j.jacc.2008.08.071 · DOI
  117. Disertori, 2009, Valsartan for prevention of recurrent atrial fibrillation, N Engl J Med, 360, 1606, 10.1056/NEJMoa0805710 · DOI · Paper page
  118. Savelieva, 2008, Statins and polyunsaturated fatty acids for treatment of atrial fibrillation, Nat Clin Pract Cardiovasc Med, 5, 30, 10.1038/ncpcardio1038 · DOI
  119. Savelieva, 2010, Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance, Naunyn Schmiedebergs Arch Pharmacol, 381, 1
  120. Santangeli, 2010, Usefulness of statins in preventing atrial fibrillation in patients with permanent pacemaker: a systematic review, Europace, 12, 649, 10.1093/europace/euq044 · DOI
  121. Patti, 2006, Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study, Circulation, 114, 1455, 10.1161/CIRCULATIONAHA.106.621763 · DOI · Paper page
  122. Liakopoulos, 2009, Statins for prevention of atrial fibrillation after cardiac surgery: a systematic literature review, J Thorac Cardiovasc Surg, 138
  123. Almroth, 2009, Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study, Eur Heart J, 30, 827, 10.1093/eurheartj/ehp006 · DOI
  124. Fauchier, 2008, Antiarrhythmic effect of statin therapy and atrial fibrillation: a meta-analysis of randomized controlled trials, J Am Coll Cardiol, 51, 828, 10.1016/j.jacc.2007.09.063 · DOI · Paper page
  125. Liu, 2008, Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies, Int J Cardiol, 126, 160, 10.1016/j.ijcard.2007.07.137 · DOI
  126. Saravanan, 2009, Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial, Circ Arrhythm Electrophysiol, 3, 46, 10.1161/CIRCEP.109.899633 · DOI · Paper page
  127. Heidarsdottir, 2010, Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?, Europace, 12, 356, 10.1093/europace/eup429 · DOI
  128. Bertini, 2010, Prediction of atrial fibrillation in patients with implantable cardioverter-defibrillator and heart failure, Eur J Heart Fail, 10.1093/eurjhf/hfq126 · DOI
  129. Fauchier, 2009, Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure, Am J Cardiol, 103, 248, 10.1016/j.amjcard.2008.09.064 · DOI
  130. Nasr, 2007, Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis, Eur Heart J, 28, 457, 10.1093/eurheartj/ehl484 · DOI · Paper page
  131. Farshi, 1999, Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens, J Am Coll Cardiol, 33, 304, 10.1016/S0735-1097(98)00561-0 · DOI · Paper page
  132. Kumar, 1996, Intravenous amiodarone for therapy of atrial fibrillation and flutter in critically ill patients with severely depressed left ventricular function, South Med J, 89, 779, 10.1097/00007611-199608000-00005 · DOI
  133. Gasparini, 2009, Cardiac resynchronization therapy in heart failure patients with atrial fibrillation, Europace, 11, v82, 10.1093/europace/eup273 · DOI
  134. Deedwania, 1998, Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators, Circulation, 98, 2574, 10.1161/01.CIR.98.23.2574 · DOI · Paper page
  135. Shelton, 2009, A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study), Heart, 95, 924, 10.1136/hrt.2008.158931 · DOI · Paper page
  136. Mozaffarian, 2008, Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study, Circulation, 118, 800, 10.1161/CIRCULATIONAHA.108.785626 · DOI · Paper page
  137. Mont, 2002, Long-lasting sport practice and lone atrial fibrillation, Eur Heart J, 23, 477, 10.1053/euhj.2001.2802 · DOI · Paper page
  138. Calvo, 2010, Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes, Europace, 12, 30, 10.1093/europace/eup320 · DOI · Paper page
  139. Wyse, 2009, Pharmacotherapy for rhythm management in elderly patients with atrial fibrillation, J Interv Card Electrophysiol, 25, 25, 10.1007/s10840-008-9329-8 · DOI
  140. Eliahou, 1978, Propranolol for the treatment of hypertension in pregnancy, Br J Obstet Gynaecol, 85, 431, 10.1111/j.1471-0528.1978.tb14909.x · DOI
  141. Bates, 2008, Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition), Chest, 133, 10.1378/chest.08-0761 · DOI · Paper page
  142. Crystal, 2004, Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery, Cochrane Database Syst Rev, 4, 10.1002/14651858.CD003611.pub2 · DOI
  143. Burgess, 2006, Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis, Eur Heart J, 27, 2846, 10.1093/eurheartj/ehl272 · DOI · Paper page
  144. Bagshaw, 2006, Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis, Ann Thorac Surg, 82, 1927, 10.1016/j.athoracsur.2006.06.032 · DOI
  145. Patel, 2006, Safety of amiodarone in the prevention of postoperative atrial fibrillation: a meta-analysis, Am J Health Syst Pharm, 63, 829, 10.2146/ajhp050454 · DOI
  146. Buckley, 2007, Amiodarone prophylaxis for atrial fibrillation after cardiac surgery: meta-analysis of dose response and timing of initiation, Pharmacotherapy, 27, 360, 10.1592/phco.27.3.360 · DOI
  147. Miller, 2005, Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis, Heart, 91, 618, 10.1136/hrt.2004.033811 · doi:10.1136/hrt.2004.033811
  148. Daoud, 2003, Temporary atrial epicardial pacing as prophylaxis against atrial fibrillation after heart surgery: a meta-analysis, J Cardiovasc Electrophysiol, 14, 127, 10.1046/j.1540-8167.2003.02371.x · doi:10.1046/j.1540-8167.2003.02371.x
  149. Dunning, 2006, Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery, Eur J Cardiothorac Surg, 30, 852, 10.1016/j.ejcts.2006.09.003 · DOI · Paper page
  150. Daoud, 2004, Management of atrial fibrillation in the post-cardiac surgery setting, Cardiol Clin, 22, 159, 10.1016/S0733-8651(03)00136-X · doi:10.1016/s0733-8651(03)00136-x
  151. Wellens, 2005, Should catheter ablation be performed in asymptomatic patients with Wolff–Parkinson–White syndrome? When to perform catheter ablation in asymptomatic patients with a Wolff–Parkinson–White electrocardiogram, Circulation, 112, 2201, 10.1161/CIRCULATIONAHA.104.483321 · DOI
  152. Chen, 2004, Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy, Am J Cardiol, 93, 373, 10.1016/j.amjcard.2003.10.025 · DOI
  153. Maron, 2002, Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy, J Am Coll Cardiol, 39, 301, 10.1016/S0735-1097(01)01727-2 · DOI · Paper page

Cited by

See all 5,864

Metadata

Authors
Developed with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors/Task Force Members, Camm, A. J., Kirchhof, P., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Van Gelder, I. C., Al-Attar, N., Hindricks, G., Prendergast, B., Heidbuchel, H., Alfieri, O., Angelini, A., Atar, D., Colonna, P., De Caterina, R., De Sutter, J., Goette, A., Gorenek, B., Heldal, M., Hohloser, S. H., Kolh, P., Le Heuzey, J.-Y., Ponikowski, P., Rutten, F. H., ESC Committee for Practice Guidelines (CPG), Vahanian, A., Auricchio, A., Bax, J., Ceconi, C., Dean, V., Filippatos, G., Funck-Brentano, C., Hobbs, R., Kearney, P., McDonagh, T., Popescu, B. A., Reiner, Z., Sechtem, U., Sirnes, P. A., Tendera, M., Vardas, P. E., Widimsky, P., Reviewers, D., Vardas, P. E., Agladze, V., Aliot, E., Balabanski, T., Blomstrom-Lundqvist, C., Capucci, A., Crijns, H., Dahlof, B., Folliguet, T., Glikson, M., Goethals, M., Gulba, D. C., Ho, S. Y., Klautz, R. J. M., Kose, S., McMurray, J., Perrone Filardi, P., Raatikainen, P., Salvador, M. J., Schalij, M. J., Shpektor, A., Sousa, J., Stepinska, J., Uuetoa, H., Zamorano, J. L., & Zupan, I.
Venue
European Heart Journal
Publisher
Oxford University Press (OUP)
Published
2010-08-29
Volume
31
Issue
19
Pages
2369-2429
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
DOI
10.1093/eurheartj/ehq278
OpenAlex
W2164861810
Cited by
5,864
References
48
FWCI
416.14
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). https://app.cochat.ai/papers/10.1093/eurheartj/ehq278
The paper
Developed with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors/Task Force Members, Camm, A. J., Kirchhof, P., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Van Gelder, I. C., Al-Attar, N., Hindricks, G., Prendergast, B., Heidbuchel, H., Alfieri, O., Angelini, A., Atar, D., Colonna, P., De Caterina, R., . . . Zupan, I. (2010). Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European Heart Journal. https://doi.org/10.1093/eurheartj/ehq278

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.